Celexa Information from Forest Laboratories, Inc.
Drug producer’s official website that provides information on Celexa.
Celexa Information from the FDA
Information about Celexa from the Drug Evaluation and Research of FDA.
MedlinePlus Drug Information: Citalopram (marketed as Celexa)
Information about Celexa from the US National Library of Medicine and the National Institute of Health.
Public Health Advisory: Serotonin Syndrome
Information from FDA regarding the combined use of triptans to cure migraine headaches and selective serotonin reuptake inhibitors including Celexa and other anti-depressants, which may result in life-threatening serotonin syndrome.
Public Health Advisory: Treatment Challenges of Depression in Pregnancy
Provides information from the FDA about the use of selective serotonin reuptake inhibitors like Celexa and other anti-depressants during pregnancy.
Antidepressant Use in Children, Adolescents, and Adults
Information from FDA with the request that producers of all antidepressant medicines include and/or warning statements notifying doctors to an increased risks of suicidal thoughts and behavior in children and adolescents who are using these drugs.
FDA Public Health Advisory: Suicidality in Adults Being Treated with Antidepressant Medications
Information from FDA, as part of its continuing efforts to study the risks of suicidal behavior in adults who are being cured with antidepressant medicines.
Information on the diagnosis, medications, and other data about depression from the National Cancer Institute and the US National Institute of Health.
An article published by FDA Consumer Magazine, January-February 2003.
International Foundation for Research and Education on Depression (iFred.org)
Information and sources from iFred, an organization which caters to the research of the causes of depression and promoting those dealing with depression.
Information regarding depression from the National Mental Health Association, a non-profit organization, which is committed to attending to all aspects of mental health and mental illnesses.
Information from the FDA’s Office of Women’s Health.